Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Injected Vaccine Could Help Eradicate Polio

Published: Friday, July 11, 2014
Last Updated: Friday, July 11, 2014
Bookmark and Share
Re-introducing a type of polio vaccine that fell out of favour in the 1960s could hasten eradication of the disease.

Published in The Lancet, the study by Imperial College London and the Christian Medical College in Vellore, India, suggests that the injected polio vaccine (IPV), which is rarely used today in countries affected by polio, could provide better and longer lasting protection against infection if used in combination with the more commonly used live oral polio vaccine (OPV). 

Vaccination protects an individual against contracting polio, but they can still be infected by the virus, which replicates in the gut and can be passed to others through contact with infected faeces. This has led to serious polio outbreaks in Asia, Africa and Europe over the last 10 years and is hampering efforts to eradicate the disease. 

Most vaccination campaigns use multiple doses of OPV that provide some gut immunity, although this wanes over time.

"Because IPV is injected into the arm, rather than taken orally, it's been assumed it doesn't provide much protection in the gut and so would be less effective at preventing faecal transmission than OPV," explains Dr Jacob John, Associate Professor at the Christian Medical College, who led the study. "However, we found that where the children already had a level of immunity due to OPV, the injected vaccine actually boosted their gut immunity. 

"In the 1960s there was extensive rivalry between the scientists who developed the two vaccines, with OPV eventually becoming the most popular. But it looks as if the strongest immunity can been achieved through a combination of the two."

The study involved 450 children from a densely populated urban area in Vellore, India, all of whom had received the oral polio vaccine as part of a standard vaccination programme. Half of the children were given a dose of the injected vaccine and half given nothing. One month later, the children were given a 'challenge' dose of the live oral vaccine to simulate reinfection. 

Their stools were tested after seven days to see if the virus was present, specifically the two remaining serotypes of the virus which are resisting eradication - serotype 1 and serotype 3. In the children who had received the IPV, the researchers found that 38 per cent fewer had serotype 1 in their stool and 70 percent fewer had serotype 3, compared to those who had not been given the injected vaccine.

"Our findings show that an additional dose of the injected vaccine is more effective at boosting immunity against infection than the oral vaccine alone," says Nick Grassly, Professor of Vaccine Epidemiology at Imperial College London, senior author of the study. "This implies that the IPV could be used to boost immunity in people travelling from or to polio-infected countries, such as Afghanistan, Pakistan and Nigeria. It could also replace some of the OPV doses in immunisation campaigns to boost gut immunity, particularly in areas of poor sanitation."

In another study published this week in Proceedings of the National Academy of Sciences, Imperial researchers from the same group looked at whether expanding the age range of vaccination campaigns to include older children and adults would help to prevent polio transmission. Using a mathematical model to examine disease transmission in two major polio outbreaks in Tajikistan and the Republic of Congo in 2010, they found that older ages contributed significantly to transmission in Congo but not Tajikistan, which might be related to standards of sanitation and hygiene. However, launching mass immunisation campaigns more quickly in response to outbreaks would have a much bigger impact than expanding the age range, the study reported.

Lead author Dr Isobel Blake from the Medical Research Council Centre for Outbreak Analysis and Modelling at Imperial College London said: "It can take over 70 days to send stool samples to the lab and get back a diagnosis of polio, which means by the time authorities discover an outbreak, many more people are already infected. These findings suggest that methods to detect outbreaks earlier would be hugely beneficial to eradication efforts."

The Lancet study was funded by the Bill & Melinda Gates Foundation. The PNAS study was supported by a grant from the Polio Research Committee of the World Health Organization, the Royal Society, and Centre funding from the Medical Research Council.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Tuesday, July 26, 2016
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Tuesday, July 26, 2016
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
Friday, July 15, 2016
Sound Waves May Hold Potential to Treat Twin Pregnancy Complications
Researchers at Imperial College London have found that the high energy sound waves could treat a potentially deadly complication that affects some twin pregnancies.
Friday, July 15, 2016
Viral hepatitis kills as Many as Malaria, TB or HIV/AIDS
Viral hepatitis is one of the leading killers across the globe, with a death toll that matches AIDS or tuberculosis.
Thursday, July 07, 2016
Supplement May Switch off Cravings for High-Calorie Foods
Researchers have found that inulin-propionate ester supplement curbs cravings for junk food.
Saturday, July 02, 2016
Dengue Virus Exposure May Amplify Zika Infection
Researchers at Imperial College London have found that the previous exposure to the dengue virus may increase the potency of Zika infection.
Friday, June 24, 2016
£14m EU Project To Aid Meningitis Diagnosis and Cut Antibiotic Use
An international team of doctors are aiming to develop a rapid test to allow medics to quickly identify bacterial infection in children.
Wednesday, June 22, 2016
New Bio-Glass Could Make it Possible to Re-Grow or Replace Cartilage
Researchers at Imperial College London have developed a material that can mimic cartilage and potentially encourage it to re-grow.
Wednesday, May 18, 2016
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Tuesday, May 17, 2016
Crucial Reaction for Vision Revealed
Scientists have tracked the reaction of a protein responding to light, paving the way for a new understanding of life's essential reactions.
Monday, May 16, 2016
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
Saturday, May 14, 2016
The Brain on LSD: New Scans Show How the Drug Affects the Brain
Researchers at Imperial College London have visualised the effects of LSD on the brain.
Tuesday, April 12, 2016
Cost of Diabetes Hits 825 Billion Dollars a Year
The global cost of diabetes is now 825 billion dollars per year, according to the largest ever study of diabetes levels across the world.
Thursday, April 07, 2016
World's Obese Population Hits 640 Million
More than one in ten men and one in seven women across the globe are now obese, according to the world's biggest obesity study.
Friday, April 01, 2016
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Genome of 6000-Year-Old Barley Sequenced
Researchers have successfully sequenced the genome of Chalcolithic barley grains for the first time.
3D Models May Yield Ovarian Cancer Insights
Researchers are developing new tools to decipher ovarian cancer developments through a 3D printing technology.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!